Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRd in Relapsed/Refractory Multiple Myeloma
NCT01701076Phase 2Completed
- Start
- Mar 2012
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in multiple myeloma (MM). Started Mar 2012; status: completed.
02
Drugs
bendamustine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01701076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01701076.